Cargando…

Conditions, pathogenesis, and progression of diabetic kidney disease and early decliner in Japan

OBJECTIVE: Glomerular filtration rate (GFR) decreases without or prior to the development of albuminuria in many patients with diabetes. Therefore, albuminuria and/or a low GFR in patients with diabetes is referred to as diabetic kidney disease (DKD). A certain proportion of patients with diabetes s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshida, Yui, Kashiwabara, Kosuke, Hirakawa, Yosuke, Tanaka, Tetsuhiro, Noso, Shinsuke, Ikegami, Hiroshi, Ohsugi, Mitsuru, Ueki, Kohjiro, Mita, Tomoya, Watada, Hirotaka, Koya, Daisuke, Mise, Koki, Wada, Jun, Shimizu, Miho, Wada, Takashi, Ito, Yumi, Narita, Ichiei, Kashihara, Naoki, Nangaku, Masaomi, Matsuyama, Yutaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Epidemiology/Health Services Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206926/ https://www.ncbi.nlm.nih.gov/pubmed/32205326 http://dx.doi.org/10.1136/bmjdrc-2019-000902

Ejemplares similares

Randomized, double-blind, placebo-controlled phase 3 study of bardoxolone methyl in patients with diabetic kidney disease: design and baseline characteristics of the AYAME study
por: Nangaku, Masaomi, et al.
Publicado: (2022)

Renal Hypoxia in CKD; Pathophysiology and Detecting Methods
por: Hirakawa, Yosuke, et al.
Publicado: (2017)

Mechanisms of metabolic memory and renal hypoxia as a therapeutic target in diabetic kidney disease
por: Hirakawa, Yosuke, et al.
Publicado: (2017)

Efficacy and safety of esaxerenone (CS-3150) in Japanese patients with type 2 diabetes and macroalbuminuria: a multicenter, single-arm, open-label phase III study
por: Ito, Sadayoshi, et al.
Publicado: (2021)

A circulating permeability factor in focal segmental glomerulosclerosis: the hunt continues
por: Wada, Takehiko, et al.
Publicado: (2015)

Downregulation of miR-205 Modulates Cell Susceptibility to Oxidative and Endoplasmic Reticulum Stresses in Renal Tubular Cells
por: Muratsu-Ikeda, Shiyo, et al.
Publicado: (2012)

Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease Database
por: Nagasu, Hajime, et al.
Publicado: (2021)

Reduction in the magnitude of serum potassium elevation in combination therapy with esaxerenone (CS‐3150) and sodium–glucose cotransporter 2 inhibitor in patients with diabetic kidney disease: Subanalysis of two phase III studies
por: Shikata, Kenichi, et al.
Publicado: (2022)

The renoprotective effect of esaxerenone independent of blood pressure lowering: a post hoc mediation analysis of the ESAX-DN trial
por: Okuda, Yasuyuki, et al.
Publicado: (2022)

Patient Satisfaction and Clinical Efficacy of Flash Glucose Monitoring in Patients with Type 1 Diabetes: A Prospective, Single-Center, Single-Arm Study
por: Ueno, Keisuke, et al.
Publicado: (2020)

Clinico-pathological features of kidney disease in diabetic cases
por: Furuichi, Kengo, et al.
Publicado: (2018)

Comparison of effectiveness and drug cost between dipeptidyl peptidase‐4 inhibitor and biguanide as the first‐line anti‐hyperglycaemic medication among Japanese working generation with type 2 diabetes
por: Ihana‐Sugiyama, Noriko, et al.
Publicado: (2019)

Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan
por: Tanaka, Tetsuhiro, et al.
Publicado: (2018)

Potential progression biomarkers of diabetic kidney disease determined using comprehensive machine learning analysis of non-targeted metabolomics
por: Hirakawa, Yosuke, et al.
Publicado: (2022)

A distinctive distribution of hypoxia‐inducible factor‐1α in cultured renal tubular cells with hypoperfusion simulated by coverslip placement
por: Honda, Tomoko, et al.
Publicado: (2020)

New measures against chronic kidney diseases in Japan since 2018
por: Fukui, Akira, et al.
Publicado: (2019)

Recent advances in understanding of chronic kidney disease
por: Yamaguchi, Junna, et al.
Publicado: (2015)

Recent advances in renal regeneration
por: Hasegawa, Sho, et al.
Publicado: (2019)

Profile of Daprodustat in the Treatment of Renal Anemia Due to Chronic Kidney Disease
por: Ishii, Taisuke, et al.
Publicado: (2021)

Exploring molecular targets in diabetic kidney disease
por: Maruno, Sayako, et al.
Publicado: (2022)

Poorly controlled type 2 diabetes with no progression of diabetes-related complications and low levels of advanced glycation end products: A Case report
por: Nakamura, Tomoka, et al.
Publicado: (2019)

Left Hemiplegia Possibly Due to Glucose Reperfusion Injury after Recovery of Severe Hypoglycemia in a Woman with Type 2 Diabetes Mellitus
por: Sugito, Erika, et al.
Publicado: (2021)

Influence of the COVID-19 Pandemic on Overall Physician Visits and Telemedicine Use Among Patients With Type 1 or Type 2 Diabetes in Japan
por: Yagome, Susumu, et al.
Publicado: (2022)

Efficacy, safety and tolerability of imeglimin in patients with type 2 diabetes mellitus: A meta‐analysis of randomized controlled trials
por: Hagi, Katsuhiko, et al.
Publicado: (2023)

Effect of patient characteristics on the efficacy and safety of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus: A post‐hoc analysis of two randomized, placebo‐controlled trials
por: Hagi, Katsuhiko, et al.
Publicado: (2023)

The role of oxidative stress and hypoxia in renal disease
por: Honda, Tomoko, et al.
Publicado: (2019)

β‐Cell failure in diabetes: Common susceptibility and mechanisms shared between type 1 and type 2 diabetes
por: Ikegami, Hiroshi, et al.
Publicado: (2021)

Insulin‐dependent diabetes mellitus in older adults: Current status and future prospects
por: Ikegami, Hiroshi, et al.
Publicado: (2022)

Genome-wide analysis revealed that DZNep reduces tubulointerstitial fibrosis via down-regulation of pro-fibrotic genes
por: Mimura, Imari, et al.
Publicado: (2018)

eGFR slope as a surrogate endpoint for clinical study in early stage of chronic kidney disease: from The Japan Chronic Kidney Disease Database
por: Itano, Seiji, et al.
Publicado: (2023)

Evaluation of cellular and humoral autoimmunity before the development of type 1 diabetes in a patient with idiopathic CD4 lymphocytopenia
por: Maruyama, Koji, et al.
Publicado: (2019)

Inflammation and hypoxia linked to renal injury by CCAAT/enhancer-binding protein δ
por: Yamaguchi, Junna, et al.
Publicado: (2015)

Treatment of Diabetic Kidney Disease: Current and Future
por: Yamazaki, Tomotaka, et al.
Publicado: (2021)

Novel lnc RNA regulated by HIF‐1 inhibits apoptotic cell death in the renal tubular epithelial cells under hypoxia
por: Mimura, Imari, et al.
Publicado: (2017)

Retrospective nationwide study on the trends in first‐line antidiabetic medication for patients with type 2 diabetes in Japan
por: Bouchi, Ryotaro, et al.
Publicado: (2021)

Proportion of subsequent clinic visits among persons without regular clinic visits who were screened as having hyperglycemia: A retrospective cohort study
por: Matsumura, Hiroshi, et al.
Publicado: (2023)

Acetate attenuates kidney fibrosis in an oxidative stress‐dependent manner
por: Kawabata, Chiaki, et al.
Publicado: (2023)

Genetics and pathogenesis of type 1 diabetes: prospects for prevention and intervention
por: Ikegami, Hiroshi, et al.
Publicado: (2011)

Maturity-Onset diabetes of the young type 5 treated with the glucagon-like peptide-1 receptor agonist: A case report
por: Terakawa, Aiko, et al.
Publicado: (2020)

Factors associated with the degree of glycemic deterioration among patients with type 2 diabetes who dropped out of diabetes care: A longitudinal analysis using medical claims and health checkup data in Japan
por: Ihana‐Sugiyama, Noriko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bfaettmg78fgb70jviueikqi6i